Global Preterm Birth Prevention and Treatment Market Research Report 2023
Preterm birth is among the prevalent public health concerns all over the world and has become the primary cause of mortality in children aging below 5 years. To curb the alarming situation, governments including, the Food and Drug Administration (FDA), are showing immediacy in approving drugs for preterm birth prevention and management.
According to QYResearch’s new survey, global Preterm Birth Prevention and Treatment market is projected to reach US$ 1760.1 million in 2029, increasing from US$ 1412 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Preterm Birth Prevention and Treatment market research.
The preterm birth prevention and management market is driven by the increasing awareness about the adverse effects of preterm birth on neonatal health and the growing emphasis on maternal and child healthcare. Preterm birth, defined as delivery before 37 weeks of pregnancy, poses significant risks to both the baby and the mother. Advances in medical research and technology have led to the development of various interventions and treatments to prevent and manage preterm birth, such as progesterone supplements, cervical cerclage, and improved prenatal care. Additionally, rising healthcare expenditure and government initiatives aimed at reducing preterm birth rates are contributing to the market's growth. However, challenges include the complex and multifactorial nature of preterm birth, making it difficult to predict and prevent in all cases. The effectiveness of interventions can vary depending on individual patient factors, leading to a need for personalized treatment approaches. Furthermore, access to quality healthcare and specialized facilities can be a challenge in some regions, impacting the implementation of effective preterm birth prevention and management strategies. As healthcare systems continue to evolve and research in this field progresses, the preterm birth prevention and management market is expected to witness advancements that improve maternal and neonatal outcomes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Preterm Birth Prevention and Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Preterm Birth Prevention and Treatment market is projected to reach US$ 1760.1 million in 2029, increasing from US$ 1412 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Preterm Birth Prevention and Treatment market research.
The preterm birth prevention and management market is driven by the increasing awareness about the adverse effects of preterm birth on neonatal health and the growing emphasis on maternal and child healthcare. Preterm birth, defined as delivery before 37 weeks of pregnancy, poses significant risks to both the baby and the mother. Advances in medical research and technology have led to the development of various interventions and treatments to prevent and manage preterm birth, such as progesterone supplements, cervical cerclage, and improved prenatal care. Additionally, rising healthcare expenditure and government initiatives aimed at reducing preterm birth rates are contributing to the market's growth. However, challenges include the complex and multifactorial nature of preterm birth, making it difficult to predict and prevent in all cases. The effectiveness of interventions can vary depending on individual patient factors, leading to a need for personalized treatment approaches. Furthermore, access to quality healthcare and specialized facilities can be a challenge in some regions, impacting the implementation of effective preterm birth prevention and management strategies. As healthcare systems continue to evolve and research in this field progresses, the preterm birth prevention and management market is expected to witness advancements that improve maternal and neonatal outcomes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Preterm Birth Prevention and Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- AMAG Pharmaceuticals
- Ferring Pharmaceutical
- Teva
- Allergan
- AbbVie
- Aurobindo Pharma
- Bayer
- Viatris
- Pfizer
- Merck & Co
- Novartis
- Sanofi
- Progesterone Therapy
- Corticosteroid Therapy
- Tocolytics Therapy
- Antihypertensive Therapy
- Magnesium Sulfate Therapy
- Other
- Hospital
- Drugs Stores
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Progesterone Therapy
1.2.3 Corticosteroid Therapy
1.2.4 Tocolytics Therapy
1.2.5 Antihypertensive Therapy
1.2.6 Magnesium Sulfate Therapy
1.2.7 Other
1.3 Market by Application
1.3.1 Global Preterm Birth Prevention and Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Preterm Birth Prevention and Treatment Market Perspective (2018-2029)
2.2 Preterm Birth Prevention and Treatment Growth Trends by Region
2.2.1 Global Preterm Birth Prevention and Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Preterm Birth Prevention and Treatment Historic Market Size by Region (2018-2023)
2.2.3 Preterm Birth Prevention and Treatment Forecasted Market Size by Region (2024-2029)
2.3 Preterm Birth Prevention and Treatment Market Dynamics
2.3.1 Preterm Birth Prevention and Treatment Industry Trends
2.3.2 Preterm Birth Prevention and Treatment Market Drivers
2.3.3 Preterm Birth Prevention and Treatment Market Challenges
2.3.4 Preterm Birth Prevention and Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Preterm Birth Prevention and Treatment Players by Revenue
3.1.1 Global Top Preterm Birth Prevention and Treatment Players by Revenue (2018-2023)
3.1.2 Global Preterm Birth Prevention and Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Preterm Birth Prevention and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preterm Birth Prevention and Treatment Revenue
3.4 Global Preterm Birth Prevention and Treatment Market Concentration Ratio
3.4.1 Global Preterm Birth Prevention and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preterm Birth Prevention and Treatment Revenue in 2022
3.5 Preterm Birth Prevention and Treatment Key Players Head office and Area Served
3.6 Key Players Preterm Birth Prevention and Treatment Product Solution and Service
3.7 Date of Enter into Preterm Birth Prevention and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PRETERM BIRTH PREVENTION AND TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global Preterm Birth Prevention and Treatment Historic Market Size by Type (2018-2023)
4.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Type (2024-2029)
5 PRETERM BIRTH PREVENTION AND TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global Preterm Birth Prevention and Treatment Historic Market Size by Application (2018-2023)
5.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Preterm Birth Prevention and Treatment Market Size (2018-2029)
6.2 North America Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
6.4 North America Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Preterm Birth Prevention and Treatment Market Size (2018-2029)
7.2 Europe Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
7.4 Europe Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Preterm Birth Prevention and Treatment Market Size (2018-2029)
8.2 Asia-Pacific Preterm Birth Prevention and Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Preterm Birth Prevention and Treatment Market Size (2018-2029)
9.2 Latin America Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
9.4 Latin America Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Preterm Birth Prevention and Treatment Market Size (2018-2029)
10.2 Middle East & Africa Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Company Detail
11.1.2 AMAG Pharmaceuticals Business Overview
11.1.3 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Introduction
11.1.4 AMAG Pharmaceuticals Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.1.5 AMAG Pharmaceuticals Recent Development
11.2 Ferring Pharmaceutical
11.2.1 Ferring Pharmaceutical Company Detail
11.2.2 Ferring Pharmaceutical Business Overview
11.2.3 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Introduction
11.2.4 Ferring Pharmaceutical Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.2.5 Ferring Pharmaceutical Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Preterm Birth Prevention and Treatment Introduction
11.3.4 Teva Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.3.5 Teva Recent Development
11.4 Allergan
11.4.1 Allergan Company Detail
11.4.2 Allergan Business Overview
11.4.3 Allergan Preterm Birth Prevention and Treatment Introduction
11.4.4 Allergan Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.4.5 Allergan Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Detail
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Preterm Birth Prevention and Treatment Introduction
11.5.4 AbbVie Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.5.5 AbbVie Recent Development
11.6 Aurobindo Pharma
11.6.1 Aurobindo Pharma Company Detail
11.6.2 Aurobindo Pharma Business Overview
11.6.3 Aurobindo Pharma Preterm Birth Prevention and Treatment Introduction
11.6.4 Aurobindo Pharma Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.6.5 Aurobindo Pharma Recent Development
11.7 Bayer
11.7.1 Bayer Company Detail
11.7.2 Bayer Business Overview
11.7.3 Bayer Preterm Birth Prevention and Treatment Introduction
11.7.4 Bayer Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.7.5 Bayer Recent Development
11.8 Viatris
11.8.1 Viatris Company Detail
11.8.2 Viatris Business Overview
11.8.3 Viatris Preterm Birth Prevention and Treatment Introduction
11.8.4 Viatris Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.8.5 Viatris Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Preterm Birth Prevention and Treatment Introduction
11.9.4 Pfizer Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Merck & Co
11.10.1 Merck & Co Company Detail
11.10.2 Merck & Co Business Overview
11.10.3 Merck & Co Preterm Birth Prevention and Treatment Introduction
11.10.4 Merck & Co Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.10.5 Merck & Co Recent Development
11.11 Novartis
11.11.1 Novartis Company Detail
11.11.2 Novartis Business Overview
11.11.3 Novartis Preterm Birth Prevention and Treatment Introduction
11.11.4 Novartis Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.11.5 Novartis Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Preterm Birth Prevention and Treatment Introduction
11.12.4 Sanofi Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.12.5 Sanofi Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Progesterone Therapy
1.2.3 Corticosteroid Therapy
1.2.4 Tocolytics Therapy
1.2.5 Antihypertensive Therapy
1.2.6 Magnesium Sulfate Therapy
1.2.7 Other
1.3 Market by Application
1.3.1 Global Preterm Birth Prevention and Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Preterm Birth Prevention and Treatment Market Perspective (2018-2029)
2.2 Preterm Birth Prevention and Treatment Growth Trends by Region
2.2.1 Global Preterm Birth Prevention and Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Preterm Birth Prevention and Treatment Historic Market Size by Region (2018-2023)
2.2.3 Preterm Birth Prevention and Treatment Forecasted Market Size by Region (2024-2029)
2.3 Preterm Birth Prevention and Treatment Market Dynamics
2.3.1 Preterm Birth Prevention and Treatment Industry Trends
2.3.2 Preterm Birth Prevention and Treatment Market Drivers
2.3.3 Preterm Birth Prevention and Treatment Market Challenges
2.3.4 Preterm Birth Prevention and Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Preterm Birth Prevention and Treatment Players by Revenue
3.1.1 Global Top Preterm Birth Prevention and Treatment Players by Revenue (2018-2023)
3.1.2 Global Preterm Birth Prevention and Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Preterm Birth Prevention and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preterm Birth Prevention and Treatment Revenue
3.4 Global Preterm Birth Prevention and Treatment Market Concentration Ratio
3.4.1 Global Preterm Birth Prevention and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preterm Birth Prevention and Treatment Revenue in 2022
3.5 Preterm Birth Prevention and Treatment Key Players Head office and Area Served
3.6 Key Players Preterm Birth Prevention and Treatment Product Solution and Service
3.7 Date of Enter into Preterm Birth Prevention and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PRETERM BIRTH PREVENTION AND TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global Preterm Birth Prevention and Treatment Historic Market Size by Type (2018-2023)
4.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Type (2024-2029)
5 PRETERM BIRTH PREVENTION AND TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global Preterm Birth Prevention and Treatment Historic Market Size by Application (2018-2023)
5.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Preterm Birth Prevention and Treatment Market Size (2018-2029)
6.2 North America Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
6.4 North America Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Preterm Birth Prevention and Treatment Market Size (2018-2029)
7.2 Europe Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
7.4 Europe Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Preterm Birth Prevention and Treatment Market Size (2018-2029)
8.2 Asia-Pacific Preterm Birth Prevention and Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Preterm Birth Prevention and Treatment Market Size (2018-2029)
9.2 Latin America Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
9.4 Latin America Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Preterm Birth Prevention and Treatment Market Size (2018-2029)
10.2 Middle East & Africa Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Company Detail
11.1.2 AMAG Pharmaceuticals Business Overview
11.1.3 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Introduction
11.1.4 AMAG Pharmaceuticals Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.1.5 AMAG Pharmaceuticals Recent Development
11.2 Ferring Pharmaceutical
11.2.1 Ferring Pharmaceutical Company Detail
11.2.2 Ferring Pharmaceutical Business Overview
11.2.3 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Introduction
11.2.4 Ferring Pharmaceutical Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.2.5 Ferring Pharmaceutical Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Preterm Birth Prevention and Treatment Introduction
11.3.4 Teva Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.3.5 Teva Recent Development
11.4 Allergan
11.4.1 Allergan Company Detail
11.4.2 Allergan Business Overview
11.4.3 Allergan Preterm Birth Prevention and Treatment Introduction
11.4.4 Allergan Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.4.5 Allergan Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Detail
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Preterm Birth Prevention and Treatment Introduction
11.5.4 AbbVie Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.5.5 AbbVie Recent Development
11.6 Aurobindo Pharma
11.6.1 Aurobindo Pharma Company Detail
11.6.2 Aurobindo Pharma Business Overview
11.6.3 Aurobindo Pharma Preterm Birth Prevention and Treatment Introduction
11.6.4 Aurobindo Pharma Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.6.5 Aurobindo Pharma Recent Development
11.7 Bayer
11.7.1 Bayer Company Detail
11.7.2 Bayer Business Overview
11.7.3 Bayer Preterm Birth Prevention and Treatment Introduction
11.7.4 Bayer Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.7.5 Bayer Recent Development
11.8 Viatris
11.8.1 Viatris Company Detail
11.8.2 Viatris Business Overview
11.8.3 Viatris Preterm Birth Prevention and Treatment Introduction
11.8.4 Viatris Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.8.5 Viatris Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Preterm Birth Prevention and Treatment Introduction
11.9.4 Pfizer Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Merck & Co
11.10.1 Merck & Co Company Detail
11.10.2 Merck & Co Business Overview
11.10.3 Merck & Co Preterm Birth Prevention and Treatment Introduction
11.10.4 Merck & Co Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.10.5 Merck & Co Recent Development
11.11 Novartis
11.11.1 Novartis Company Detail
11.11.2 Novartis Business Overview
11.11.3 Novartis Preterm Birth Prevention and Treatment Introduction
11.11.4 Novartis Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.11.5 Novartis Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Preterm Birth Prevention and Treatment Introduction
11.12.4 Sanofi Revenue in Preterm Birth Prevention and Treatment Business (2018-2023)
11.12.5 Sanofi Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Progesterone Therapy
Table 3. Key Players of Corticosteroid Therapy
Table 4. Key Players of Tocolytics Therapy
Table 5. Key Players of Antihypertensive Therapy
Table 6. Key Players of Magnesium Sulfate Therapy
Table 7. Key Players of Other
Table 8. Global Preterm Birth Prevention and Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Preterm Birth Prevention and Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Preterm Birth Prevention and Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Preterm Birth Prevention and Treatment Market Share by Region (2018-2023)
Table 12. Global Preterm Birth Prevention and Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Preterm Birth Prevention and Treatment Market Share by Region (2024-2029)
Table 14. Preterm Birth Prevention and Treatment Market Trends
Table 15. Preterm Birth Prevention and Treatment Market Drivers
Table 16. Preterm Birth Prevention and Treatment Market Challenges
Table 17. Preterm Birth Prevention and Treatment Market Restraints
Table 18. Global Preterm Birth Prevention and Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Preterm Birth Prevention and Treatment Market Share by Players (2018-2023)
Table 20. Global Top Preterm Birth Prevention and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preterm Birth Prevention and Treatment as of 2022)
Table 21. Ranking of Global Top Preterm Birth Prevention and Treatment Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Preterm Birth Prevention and Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Preterm Birth Prevention and Treatment Product Solution and Service
Table 25. Date of Enter into Preterm Birth Prevention and Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Preterm Birth Prevention and Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2018-2023)
Table 29. Global Preterm Birth Prevention and Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2024-2029)
Table 31. Global Preterm Birth Prevention and Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2018-2023)
Table 33. Global Preterm Birth Prevention and Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2024-2029)
Table 35. North America Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Preterm Birth Prevention and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Preterm Birth Prevention and Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Preterm Birth Prevention and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Preterm Birth Prevention and Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Preterm Birth Prevention and Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Preterm Birth Prevention and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Preterm Birth Prevention and Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 50. AMAG Pharmaceuticals Company Detail
Table 51. AMAG Pharmaceuticals Business Overview
Table 52. AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Product
Table 53. AMAG Pharmaceuticals Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 54. AMAG Pharmaceuticals Recent Development
Table 55. Ferring Pharmaceutical Company Detail
Table 56. Ferring Pharmaceutical Business Overview
Table 57. Ferring Pharmaceutical Preterm Birth Prevention and Treatment Product
Table 58. Ferring Pharmaceutical Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 59. Ferring Pharmaceutical Recent Development
Table 60. Teva Company Detail
Table 61. Teva Business Overview
Table 62. Teva Preterm Birth Prevention and Treatment Product
Table 63. Teva Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 64. Teva Recent Development
Table 65. Allergan Company Detail
Table 66. Allergan Business Overview
Table 67. Allergan Preterm Birth Prevention and Treatment Product
Table 68. Allergan Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 69. Allergan Recent Development
Table 70. AbbVie Company Detail
Table 71. AbbVie Business Overview
Table 72. AbbVie Preterm Birth Prevention and Treatment Product
Table 73. AbbVie Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 74. AbbVie Recent Development
Table 75. Aurobindo Pharma Company Detail
Table 76. Aurobindo Pharma Business Overview
Table 77. Aurobindo Pharma Preterm Birth Prevention and Treatment Product
Table 78. Aurobindo Pharma Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 79. Aurobindo Pharma Recent Development
Table 80. Bayer Company Detail
Table 81. Bayer Business Overview
Table 82. Bayer Preterm Birth Prevention and Treatment Product
Table 83. Bayer Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 84. Bayer Recent Development
Table 85. Viatris Company Detail
Table 86. Viatris Business Overview
Table 87. Viatris Preterm Birth Prevention and Treatment Product
Table 88. Viatris Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 89. Viatris Recent Development
Table 90. Pfizer Company Detail
Table 91. Pfizer Business Overview
Table 92. Pfizer Preterm Birth Prevention and Treatment Product
Table 93. Pfizer Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 94. Pfizer Recent Development
Table 95. Merck & Co Company Detail
Table 96. Merck & Co Business Overview
Table 97. Merck & Co Preterm Birth Prevention and Treatment Product
Table 98. Merck & Co Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 99. Merck & Co Recent Development
Table 100. Novartis Company Detail
Table 101. Novartis Business Overview
Table 102. Novartis Preterm Birth Prevention and Treatment Product
Table 103. Novartis Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 104. Novartis Recent Development
Table 105. Sanofi Company Detail
Table 106. Sanofi Business Overview
Table 107. Sanofi Preterm Birth Prevention and Treatment Product
Table 108. Sanofi Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 109. Sanofi Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 1. Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Progesterone Therapy
Table 3. Key Players of Corticosteroid Therapy
Table 4. Key Players of Tocolytics Therapy
Table 5. Key Players of Antihypertensive Therapy
Table 6. Key Players of Magnesium Sulfate Therapy
Table 7. Key Players of Other
Table 8. Global Preterm Birth Prevention and Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Preterm Birth Prevention and Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Preterm Birth Prevention and Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Preterm Birth Prevention and Treatment Market Share by Region (2018-2023)
Table 12. Global Preterm Birth Prevention and Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Preterm Birth Prevention and Treatment Market Share by Region (2024-2029)
Table 14. Preterm Birth Prevention and Treatment Market Trends
Table 15. Preterm Birth Prevention and Treatment Market Drivers
Table 16. Preterm Birth Prevention and Treatment Market Challenges
Table 17. Preterm Birth Prevention and Treatment Market Restraints
Table 18. Global Preterm Birth Prevention and Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Preterm Birth Prevention and Treatment Market Share by Players (2018-2023)
Table 20. Global Top Preterm Birth Prevention and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preterm Birth Prevention and Treatment as of 2022)
Table 21. Ranking of Global Top Preterm Birth Prevention and Treatment Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Preterm Birth Prevention and Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Preterm Birth Prevention and Treatment Product Solution and Service
Table 25. Date of Enter into Preterm Birth Prevention and Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Preterm Birth Prevention and Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2018-2023)
Table 29. Global Preterm Birth Prevention and Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2024-2029)
Table 31. Global Preterm Birth Prevention and Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2018-2023)
Table 33. Global Preterm Birth Prevention and Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2024-2029)
Table 35. North America Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Preterm Birth Prevention and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Preterm Birth Prevention and Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Preterm Birth Prevention and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Preterm Birth Prevention and Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Preterm Birth Prevention and Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Preterm Birth Prevention and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Preterm Birth Prevention and Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 50. AMAG Pharmaceuticals Company Detail
Table 51. AMAG Pharmaceuticals Business Overview
Table 52. AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Product
Table 53. AMAG Pharmaceuticals Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 54. AMAG Pharmaceuticals Recent Development
Table 55. Ferring Pharmaceutical Company Detail
Table 56. Ferring Pharmaceutical Business Overview
Table 57. Ferring Pharmaceutical Preterm Birth Prevention and Treatment Product
Table 58. Ferring Pharmaceutical Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 59. Ferring Pharmaceutical Recent Development
Table 60. Teva Company Detail
Table 61. Teva Business Overview
Table 62. Teva Preterm Birth Prevention and Treatment Product
Table 63. Teva Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 64. Teva Recent Development
Table 65. Allergan Company Detail
Table 66. Allergan Business Overview
Table 67. Allergan Preterm Birth Prevention and Treatment Product
Table 68. Allergan Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 69. Allergan Recent Development
Table 70. AbbVie Company Detail
Table 71. AbbVie Business Overview
Table 72. AbbVie Preterm Birth Prevention and Treatment Product
Table 73. AbbVie Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 74. AbbVie Recent Development
Table 75. Aurobindo Pharma Company Detail
Table 76. Aurobindo Pharma Business Overview
Table 77. Aurobindo Pharma Preterm Birth Prevention and Treatment Product
Table 78. Aurobindo Pharma Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 79. Aurobindo Pharma Recent Development
Table 80. Bayer Company Detail
Table 81. Bayer Business Overview
Table 82. Bayer Preterm Birth Prevention and Treatment Product
Table 83. Bayer Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 84. Bayer Recent Development
Table 85. Viatris Company Detail
Table 86. Viatris Business Overview
Table 87. Viatris Preterm Birth Prevention and Treatment Product
Table 88. Viatris Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 89. Viatris Recent Development
Table 90. Pfizer Company Detail
Table 91. Pfizer Business Overview
Table 92. Pfizer Preterm Birth Prevention and Treatment Product
Table 93. Pfizer Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 94. Pfizer Recent Development
Table 95. Merck & Co Company Detail
Table 96. Merck & Co Business Overview
Table 97. Merck & Co Preterm Birth Prevention and Treatment Product
Table 98. Merck & Co Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 99. Merck & Co Recent Development
Table 100. Novartis Company Detail
Table 101. Novartis Business Overview
Table 102. Novartis Preterm Birth Prevention and Treatment Product
Table 103. Novartis Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 104. Novartis Recent Development
Table 105. Sanofi Company Detail
Table 106. Sanofi Business Overview
Table 107. Sanofi Preterm Birth Prevention and Treatment Product
Table 108. Sanofi Revenue in Preterm Birth Prevention and Treatment Business (2018-2023) & (US$ Million)
Table 109. Sanofi Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Preterm Birth Prevention and Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Preterm Birth Prevention and Treatment Market Share by Type: 2022 VS 2029
Figure 3. Progesterone Therapy Features
Figure 4. Corticosteroid Therapy Features
Figure 5. Tocolytics Therapy Features
Figure 6. Antihypertensive Therapy Features
Figure 7. Magnesium Sulfate Therapy Features
Figure 8. Other Features
Figure 9. Global Preterm Birth Prevention and Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Preterm Birth Prevention and Treatment Market Share by Application: 2022 VS 2029
Figure 11. Hospital Case Studies
Figure 12. Drugs Stores Case Studies
Figure 13. Other Case Studies
Figure 14. Preterm Birth Prevention and Treatment Report Years Considered
Figure 15. Global Preterm Birth Prevention and Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Preterm Birth Prevention and Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Preterm Birth Prevention and Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Preterm Birth Prevention and Treatment Market Share by Players in 2022
Figure 19. Global Top Preterm Birth Prevention and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preterm Birth Prevention and Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Preterm Birth Prevention and Treatment Revenue in 2022
Figure 21. North America Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Preterm Birth Prevention and Treatment Market Share by Country (2018-2029)
Figure 23. United States Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Preterm Birth Prevention and Treatment Market Share by Country (2018-2029)
Figure 27. Germany Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Preterm Birth Prevention and Treatment Market Share by Region (2018-2029)
Figure 35. China Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Preterm Birth Prevention and Treatment Market Share by Country (2018-2029)
Figure 43. Mexico Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Preterm Birth Prevention and Treatment Market Share by Country (2018-2029)
Figure 47. Turkey Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. AMAG Pharmaceuticals Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 50. Ferring Pharmaceutical Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 51. Teva Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 52. Allergan Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 53. AbbVie Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 54. Aurobindo Pharma Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 55. Bayer Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 56. Viatris Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 58. Merck & Co Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 59. Novartis Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 60. Sanofi Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Figure 1. Global Preterm Birth Prevention and Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Preterm Birth Prevention and Treatment Market Share by Type: 2022 VS 2029
Figure 3. Progesterone Therapy Features
Figure 4. Corticosteroid Therapy Features
Figure 5. Tocolytics Therapy Features
Figure 6. Antihypertensive Therapy Features
Figure 7. Magnesium Sulfate Therapy Features
Figure 8. Other Features
Figure 9. Global Preterm Birth Prevention and Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Preterm Birth Prevention and Treatment Market Share by Application: 2022 VS 2029
Figure 11. Hospital Case Studies
Figure 12. Drugs Stores Case Studies
Figure 13. Other Case Studies
Figure 14. Preterm Birth Prevention and Treatment Report Years Considered
Figure 15. Global Preterm Birth Prevention and Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Preterm Birth Prevention and Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Preterm Birth Prevention and Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Preterm Birth Prevention and Treatment Market Share by Players in 2022
Figure 19. Global Top Preterm Birth Prevention and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preterm Birth Prevention and Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Preterm Birth Prevention and Treatment Revenue in 2022
Figure 21. North America Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Preterm Birth Prevention and Treatment Market Share by Country (2018-2029)
Figure 23. United States Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Preterm Birth Prevention and Treatment Market Share by Country (2018-2029)
Figure 27. Germany Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Preterm Birth Prevention and Treatment Market Share by Region (2018-2029)
Figure 35. China Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Preterm Birth Prevention and Treatment Market Share by Country (2018-2029)
Figure 43. Mexico Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Preterm Birth Prevention and Treatment Market Share by Country (2018-2029)
Figure 47. Turkey Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Preterm Birth Prevention and Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. AMAG Pharmaceuticals Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 50. Ferring Pharmaceutical Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 51. Teva Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 52. Allergan Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 53. AbbVie Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 54. Aurobindo Pharma Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 55. Bayer Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 56. Viatris Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 58. Merck & Co Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 59. Novartis Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 60. Sanofi Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
